OWLT · NYSE · Medical - Devices

Owlet (OWLT)

Combines wearable infant monitoring, video, and software through its Dream product family.

$5.48
vs last close−0.05 (−0.99%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue92115212221212632272234
Cost of revenue6118101110101316141012
Gross profit3107101211111316131222
111312121618141515181820
Research & development222233344445
91110101416111211141416
Selling & marketing344444445546
General & administrative576610127769910
Other expenses000000000000
Operating income−8−3−6−2−5−7−3−21−5−52
2−491−1−16−363−42−2
Interest income000000000000
Interest expense000001111111
Other non-operating income−24−9−110−736−44−32
Income before tax−6−73−1−6−83−384−9−3−1
Income tax expense000001000000
Net income from continuing operations−6−73−1−6−93−384−9−3−1
Net income−6−73−1−6−93−384−9−3−1
EPS, basic−$0.84−$0.97$0.15−$0.30−$0.61−$0.64$0.11−$2.28$0.16−$0.39−$0.15−$0.05
EPS, diluted−$0.84−$0.97−$0.51−$0.30−$0.61−$0.64$0.11−$2.28$0.13−$0.39−$0.15−$0.05
Weighted average shares, basic88991115151617252829
Weighted average shares, diluted881091115151620252829
EBITDA−5−64−1−5−74−375−8−20
Depreciation & amortization100000000000
EBIT−6−73−1−6−84−385−9−30